Mainz Biomed N.V.
MYNZ
Market Cap$5.29M
Close$
$-3.88
275.7% downside
Current Fair Value
275.7% downsideOvervalued by 275.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.29 Million |
|---|---|
| Enterprise Value | $2.33 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.62 |
| Beta | 0.09 |
| Outstanding Shares | 21,165,482 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.26 |
|---|---|
| PEG | 0.71 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.6 |
| Enterprise Value to EBIT | -0.09 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.4 |
| Debt to Equity | 0.54 |
Revenue Sources
No data
Insider Trades
ESG Score
No data